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Summary
The Tat protein export system translocates folded
proteins across the bacterial cytoplasmic membrane
and the plant thylakoid membrane. The Tat system in
Escherichia coli is composed of TatA, TatB and TatC
proteins. TatB and TatC form an oligomeric, multiva-
lent receptor complex that binds Tat substrates, while
multiple protomers of TatA assemble at substrate-
bound TatBC receptors to facilitate substrate trans-
port. We have addressed whether oligomerisation of
TatC is an absolute requirement for operation of the
Tat pathway by screening for dominant negative
alleles of tatC that inactivate Tat function in the pres-
ence of wild-type tatC. Single substitutions that
confer dominant negative TatC activity were localised
to the periplasmic cap region. The variant TatC pro-
teins retained the ability to interact with TatB and with
a Tat substrate but were unable to support the in vivo
assembly of TatA complexes. Blue-native PAGE
analysis showed that the variant TatC proteins pro-
duced smaller TatBC complexes than the wild-type
TatC protein. The substitutions did not alter disul-
phide crosslinking to neighbouring TatC molecules
from positions in the periplasmic cap but abolished a
substrate-induced disulphide crosslink in transmem-
brane helix 5 of TatC. Our findings show that TatC
functions as an obligate oligomer.
Introduction
The targeting of proteins to their sites of cellular function is
an essential process that is carried out by conserved
protein sorting and translocation machineries. In prokary-
otes, two major protein export pathways operate in parallel
in the cytoplasmic membrane. The Sec (general secretory)
machinery is a multi-subunit complex comprising three
core components that in bacteria are termed SecY, SecE
and SecG (reviewed in Denks et al., 2014; Chatzi et al.,
2013). SecY forms the protein transport channel (Van den
Berg et al., 2004), to which substrate proteins can be
targeted in a co-translational manner by the signal recog-
nition particle (Valent et al., 1998) or post-translationally in
bacteria by the ATPase SecA (Economou and Wickner,
1994). Substrates are targeted to the Sec machinery
because they contain N-terminal signal sequences, and
they are exported in an unfolded state.
The second major protein transport system found in
prokaryotes is the Tat (twin-arginine) translocase, which
transports fully folded proteins across the cytoplasmic
membrane (reviewed in Palmer and Berks, 2012; Frobel
et al., 2012; Berks, 2015). Substrates of the Tat pathway
also contain N-terminal signal sequences, which,
although related to Sec signal peptides, differ in overall
hydrophobicity and because they contain an almost
invariant twin-arginine motif (Berks, 1996; Cristobal et al.,
1999; Stanley et al., 2000). The Tat machinery is made up
of membrane proteins of the TatA and TatC families
(Settles et al., 1997; Bogsch et al., 1998; Sargent et al.,
1998; Yen et al., 2002; Jongbloed et al., 2004). In Escheri-
chia coli, and most Gram negative bacteria, two TatA
family proteins, TatA and TatB, assume distinct roles in the
Tat protein export pathway (Sargent et al., 1998; 1999).
The TatB protein forms a stable complex with TatC,
together acting as the receptor for Tat substrates (e.g.
Bolhuis et al., 2001; Cline and Mori, 2001; Richter and
Bruser, 2005; Alami et al., 2003; Tarry et al., 2009). By
contrast, the TatA protein is found as small homomultim-
eric units that assemble into larger oligomers driven by
the protonmotive force and interaction with the substrate-
bound TatBC complex (Mori and Cline, 2002; Alami et al.,
2003; Dabney-Smith et al., 2006; Leake et al., 2008;
Alcock et al., 2013; Rose et al., 2013). Both Sec and Tat
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machineries are also found in the thylakoid membranes of
plant chloroplasts (Celedon and Cline, 2013).
The oligomeric state that the SecYEG channel adopts
during protein translocation has long been controversial.
Numerous lines of evidence have shown that purified
SecYEG complexes in detergent solution, or following
reconstitution into liposomes, are dimeric or even tetra-
meric (e.g. Breyton et al., 2002; Bessonneau et al.,
2002; Manting et al., 2000; Mitra et al., 2005). Although
a protein conducting channel is present in the SecYEG
monomer (Van den Berg et al., 2004), it has been pro-
posed that dimerisation of SecYEG is required, for
example, to activate SecA (Osborne and Rapoport,
2007; Deville et al., 2011; Dalal et al., 2012). However,
others have shown that a reconstituted SecYEG
monomer is functional for protein translocation (Kedrov
et al., 2011) and an E. coli SecY variant that cannot
support dimerisation can replace wild-type SecY in vivo
(Park and Rapoport, 2012). None-the-less, dimers of
SecYEG have been detected at endogenous levels in
E. coli (Boy and Koch, 2009). Recently, a heteromultim-
eric complex of monomeric SecYEG with SecDF–YajC–
YidC, termed the holo-translocon, has also been purified
that is particularly proficient for membrane protein
insertion (Schulze et al., 2014). It has been proposed
that SecYEG undergoes dynamic exchange between
homodimers and holo-translocons as a means to modu-
late translocation activity.
The oligomeric state of the Tat protein translocase is
also uncertain. A wide range of oligomeric states for the
TatA protein, both in vitro and in vivo, have been reported
(Gohlke et al., 2005; Oates et al., 2005; Dabney-Smith
et al., 2006; Leake et al., 2008), with multimerisation of
TatA into large assemblies being associated with protein
translocation (Dabney-Smith et al., 2006; Dabney-Smith
and Cline, 2009; Alcock et al., 2013; Rose et al., 2013).
The TatBC receptor complex is also multimeric in deter-
gent solution (e.g. Cline and Mori, 2001; Bolhuis et al.,
2001), even at native levels of expression (McDevitt et al.,
2006), and multimers of TatB and TatC have also been
detected in vivo (Alcock et al., 2013; Rose et al., 2013).
Analysis of purified TatBC complexes by negative stain
electron microscopy shows that they contain more than
one species, probably with different numbers of TatB and
TatC subunits (Oates et al., 2003; Tarry et al., 2009), and
some level of heterogeneity has also been seen for the E.
coli TatBC complex analysed by blue-native polyacryla-
mide gel electrophoresis (BN-PAGE) (e.g. Behrendt et al.,
2007; Orriss et al., 2007).
Under some circumstances, the TatBC complex also
exhibits functional multivalency. For example, single
TatBC complexes from E. coli can be purified with up to
two bound substrate proteins (Tarry et al., 2009), and in
Salmonella enterica a heterodimer of the tetrathionate
reductase A and B subunits, each with their own Tat
signal sequence, are co-translocated as a complex
where each signal sequence is likely to engage different
TatBC subunits (James et al., 2013). In plant thylakoids
up to four thylakoid substrate precursor proteins tethered
to each other by disulphide bonds can be exported in a
single step (Ma and Cline, 2010). However, it is not clear
whether the TatBC complex is an obligate multimer, or,
like SecYEG, can retain activity if oligomeric interactions
are disrupted.
Here we have addressed the question of whether the
TatBC complex is a functional oligomer by undertaking a
genetic screen to isolate mutations of tatC that prevent
function of the Tat system even when a wild-type copy of
tatC is present. The isolation of such mutations confirms
that oligomerisation of TatC is essential for operation of
the Tat pathway. Biochemical analysis of TatBC com-
plexes harbouring individual amino-acid substitutions that
confer dominant negative activity shows that the com-
plexes are of lower oligomeric state than the native TatBC
complex and that the substitutions block substrate-
induced recruitment of TatA.
Results
Isolation of dominant negative mutants of E. coli tatC
Crosslinking studies have shown that within the TatBC
complex, neighbouring TatC proteins are in close proxim-
ity (e.g. Punginelli et al., 2007; Zoufaly et al., 2012;
Aldridge et al., 2014). Moreover, a covalent TatC dimer is
stable and supports full Tat activity (Maldonado et al.,
2011a), and when produced in the absence of other Tat
components, TatC is able to self-interact to form multimers
(Behrendt et al., 2007; Orriss et al., 2007). However, the
structure of the isolated TatC protein from Aquifex aeoli-
cus in three different crystallisation environments does
not identify physiologically plausible dimer contacts
(Rollauer et al., 2012; Ramasamy et al., 2013). Therefore,
to assess whether oligomerisation of TatC is functionally
required for Tat activity, and if so to identify potential sites
of self-interaction, we undertook a screen for dominant
negative mutations of tatC.
The premise of the screen is that, if TatC is a functional
multimer, it should be possible to identify variants of TatC
that can still interact with the wild-type protein such that
they prevent the wild-type copy from working. To this end,
we screened a pre-existing random library of tatC muta-
tions present in plasmid pTAT1d (which has a ColE1 origin
and a copy number of around 20 per cell), which also
harbours the tatA and tatB genes (Maldonado et al.,
2011b; Kneuper et al., 2012). The mutant library com-
prises approximately 600,000 individual clones with an
average of 2.5 errors per tatC gene (Kneuper et al.,
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2012). Screening was undertaken in strain MC4100,
which encodes the native chromosomal copy of tatABC.
The first round of screening utilised a positive selection for
loss of Tat function based on the export of chlorampheni-
col acetyltransferase (CAT) fused to the E. coli TorA Tat
signal peptide (Maldonado et al., 2011b). Since CAT is
only active in the cytoplasm because it requires a source
of acetyl CoA, export by the Tat system renders cells
sensitive to growth in the presence of chloramphenicol,
whereas inactivation of Tat function provides resistance.
We screened more than 2 million transformants in
MC4100 and found approximately 4000 that could grow in
the presence of 200 μg ml−1 chloramphenicol.
Next we took a subset of 700 of the chloramphenicol-
resistant transformants and subjected them to two addi-
tional phenotypic screening tests that also assess Tat
functionality. Screening in the presence of 2% SDS
assesses the ability of E. coli to export the Tat-dependent
amidase enzymes, AmiA and AmiC, that are involved in
cell wall remodelling (Buchanan et al., 2002; Ize et al.,
2003), while screening for anaerobic growth with
trimethylamine-N-oxide (TMAO) as sole electron acceptor
assesses whether the Tat-dependent TMAO and dimeth-
ylsulphoxide reductases have been exported (Sargent
et al., 1998; Weiner et al., 1998). From this we found 97
clones that were defective for growth on one or both of
these selective media (Tables 1 and 2).
The sequence of the plasmid-encoded tatABC genes in
each of these strains was subsequently determined, and
the tatC alleles fell into two broad categories. The first,
shown in Table 1, had one or more point mutations within
the tatC sequence but, with the exception of clone #726,
encoded a full-length TatC. The second (Table 2) had
mutations leading to the generation of a TatBC fusion
protein along with additional mutations, frequently prema-
ture stop codons, within the tatC gene.
Individual dominant negative substitutions in TatC
cluster in the periplasmic cap
We noted from Table 1 that although substitutions were
found throughout TatC, there was a strikingly high number
in the first and second periplasmic loops. For example,
there were 4 substitutions each at P54, M59, K73, 6 at
P48 and 27 at S66 in the first periplasmic loop, and 10 at
D150 in the second periplasmic loop. These loop regions
were previously found as hotspots for substitutions that
inactivate the function of TatC (Kneuper et al., 2012) and
form a stabilising cap over the transmembrane helices of
the protein (Rollauer et al., 2012; Ramasamy et al.,
2013). By contrast, substitutions in other regions of TatC
that have previously been highlighted by mutagenesis to
have essential roles in TatC function, for example, the first
cytoplasmic loop that is involved in signal peptide binding
(Strauch and Georgiou, 2007; Rollauer et al., 2012), were
not over-represented among the mutants isolated.
To determine which of the substitutions listed in Table 1
led to the dominant negative activity of TatC, we
re-introduced substitutions individually in TatC encoded
on plasmid pTAT1d along with tatA and tatB. In doing so,
we selected all residues in which substitutions occurred
four or more times in Table 1, and in addition, we remade
all of those clones that contained only a single substitu-
tion. Finally, as additional controls, we also included pre-
viously identified substitutions that are known to inactivate
the function of TatC that fall (a) within the periplasmic
loops (L74P – also found twice in Table 1, and V145E –
also found once in Table 1; Kneuper et al., 2012) and (b)
elsewhere on the TatC protein (F94R, G204R, M205R,
D211R and D215R; Kneuper et al., 2012). All of the single
substitutions tested are listed in Table 3.
Each plasmid-encoded substitution was introduced into
strain background DADE (which lacks all chromosomal tat
genes, allowing us to score whether the substitution inac-
tivates the function of TatC) and into MC4100 (which is
tat+, thus allowing us to score for dominance). Tat function
was then assessed using selective media containing SDS
or TMAO. As shown in Fig. 1 (top panel), most of the
individual substitutions tested severely affected the func-
tion of TatC when each variant was produced as the sole
TatC copy by preventing growth on at least one of the two
selection media, with the exception of the D5E, T11A,
F37S, K73E, F165L and C224R substitutions. The TatC
positions and nature of the TatC inactivating substitutions
were almost all previously identified by Kneuper et al.
(2012), although two novel TatC inactivating substitutions,
P54L and D150Y, were found. However, very few of these
TatC substitutions led to an inactive Tat system in the
presence of wild-type tatC (Fig. 1, bottom panel). Indeed
only five single TatC substitutions falling in either the first
(P48L, M59K and S66P) or second (V145E and D150Y)
periplasmic loop prevented growth of the wild-type strain
MC4100 on both SDS- and TMAO-containing media. We
conclude that single dominant negative amino-acid sub-
stitutions are strongly and almost exclusively associated
with the periplasmic cap of TatC. The positions of these
dominant negative TatC amino-acid substitutions are
shown in Fig. 2 on a schematic representation of TatC.
TatBC fusions show dominant negative activity when
combined with additional stop codon substitutions
A second class of TatC variant isolated after screening for
dominant negative mutations was those that encoded a
TatBC fusion protein along with other substitutions, par-
ticularly stop codons. To determine which mutations were
responsible for the dominant negative behaviour of these
clones, we dissected out some of the individual mutations
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Table 1. Amino-acid sequence changes encoded in dominant negative clones isolated from the tatC mutant library.
Clone Growth on TMAO Growth on SDS TatC substitution/s
9 − − T6I P131La N139T D150Nb W180L T184I
50 − +/− D5E A160V
62 − +/− V203D G204Eb
72 +/− +/− F37S
77 − − S114R S153C F165L G199R G238S
85 − +/− D5N M59Ib D63Va Y84C
95 +/− +/− S66Pa K255stop
128 +/− +/− R17P P67L
133 − +/− S66Lb K73E E103Vb F232S
147 +/− +/− L137Ha I151Vb V202I
151 − +/− S66Pa A96V
162 − − M59Ka K73E A133V
175 +/− +/− P54S D150Ga
182 − +/− I60Vb S66Lb
191 +/− +/− D150Yb
242 +/− − V29A A61D I151Ta F235S
260 − +/− S66Pa K192N
266 − +/− L21P S57P
287 − +/− Q52L D150Ga
291 − +/− I41V S66Pa L197Q
298 − +/− D4N S66Pa
318 − −− L53F V64Ea K101R M122R M181T E244V
320 − −− V78E H102L S148Pa
328 − − V64Ea F69S L161P
335 − − S66Lb F134Y
365 − +/− S2T I28T T70Kb L74Pa L99Qa E143V C224S
386 − +/− L21P P48La
394 − +/− L21P K51R S66Pa
404 − +/− D5Y T11S S66Lb V147Ab E254G
422 − − V64Ea F124I
429 − +/− M77K P85L S113P A123V S233L
432 +/− +/− S148Pa
444 − +/− V64Ea
457 − +/− C23Yb L111Q P142L F157I
464 +/− +/− T11A L137Pb A141S D150Yb Y154H R234C
465 − +/− Δ151Ib Δ152A
469 − +/− F130I D150Yb F169S I220T Y223C
471 − +/− S66Pa G204Wb
477 − +/− P48Qb S66Pa V173I
478 − +/− M59Ka V64Ea K101R V237A
483 +/− +/− L88P M205Ib
497 +/− +/− S66Pa A152V
505 +/− +/− S66Pa
508 +/− + P48Sa S66Pa M122V
514 − + I60F S66Pa F165I
517 +/− + S66Pb L111R V237A
520 − + S57L S66Pa
521 +/− + F31Y P54L G144R
554 − + R17H A47P G135S L161Q D188G F235L R241Q
578 − − Q52L D150Yb
586 +/− +/− V147Ea D150Ga F226S E254G
594 +/− +/− P48La M59Vb S79P V158A G199S
608 +/− + V86M F134S
611 +/− − L137Ha S148Pa
612 +/− + S66Pa S83P
621 +/− + L34P A61V F76L Q90P
626 − − V145Gb A164T
644 +/− − V64Eb R105H M181K
651 − − I60Tb V145Ea V171M
664 − − P48La F157S F165L L197Q
668 +/− + I183F G229D
674 +/− − S66Pa K73R A84V H102L G135S
679 +/− − S66Pa R190C
680 − − P54S S57L F69S L74Pa G144R
689 − − P54L F69L T70K E245D
690 +/− − N22I S66Pa
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found in clones 5, 75, 358, 364, 397 and 410 listed in
Table 2, and we also assessed the effect of the Y42 stop,
S185 stop, E187 stop, L189 stop and L218 stop mutations
that co-occurred along with a TatBC fusions encoded by
clones in Table 2. The mutations that we tested are listed
in Table 4 and the positions of the stop codon substitu-
tions are also shown on a schematic of TatC in Fig. 2.
We found that, as expected, the TatC stop codon substi-
tutions at Y42, S185, E187, L189 and L218 inactivated the
function of TatC (Fig. 3, top panel); however, they did not
show dominant negative activity when produced in a tat+
strain background (Fig. 3, bottom panel). Likewise, all
three of the TatBC fusions we tested were also able to
support Tat transport activity (Fig. 3, top panel) – again this
was not surprising as a TatBC fusion protein has been
constructed previously that retains Tat function (Bolhuis
et al., 2001). However, we did note that when these fusions
were produced in the tat+ strain, the strain failed to grow
anaerobically with TMAO as sole electron acceptor, indi-
cating that they had some degree of dominant negative
activity, although a reasonable level of growth was seen on
SDS-containing medium. When the stop codon mutations
(or in some cases co-occurring point mutations) were
additionally introduced into these fusion constructs and the
plasmids introduced into the tat+ strain MC4100, growth on
SDS was severely affected. We conclude that the TatBC
fusions display a partial dominant negative phenotype that
is compounded if TatC is C-terminally truncated.
Table 1. cont.
Clone Growth on TMAO Growth on SDS TatC substitution/s
693 +/− − L34Q S66Pa A200V R243Q
699 − − A61D; K73E; F134S
702 +/− − S66Pa V230D
706 +/− − T11K D150Yb A152V F165I
708 +/− − H12L A47V V64Mb S66Lb H102L
711 +/− +/− G182R L207P L225Pa
723 − − L13P S66Pa V147Ab
726 +/− − D5G T11A I228 frameshift
729 − − T11M S66Pa T70Mb G135S A164T R190H V202I
735 − − P48La D63Va
743 − − L20Pa F136L D150Ga
‘+’ indicates growth, ‘ + /−’ poor growth and ‘–’ no growth on the indicated selective medium. Substitutions in boldface are where the indicated
residue was found substituted on four or more occasions in the isolated clones.
a. Identical substitutions that have been previously isolated that are known to inactivate the function of TatC (Kneuper et al., 2012).
b. Substitutions at these amino-acid positions are known to inactivate TatC when substituted to something other than that identified here.
Table 2. Amino-acid sequence changes encoded in dominant
negative clones found in the context of fused TatBC isolated from the
tatC mutant library.
Clone
Growth on
TMAO
Growth
on SDS
TatC substitution/s in addition to
fused TatB–TatC
1a − +/− L49stop
5b − +/− E187stop
6a − − P8T I24F P54S D150N A152V
K191 stop
74c − − P67L W180 stop
75d − +/− P186L Y195 stop
91e − +/− I50V M205V
189f − +/− V198 frameshift
193b − +/− L20Q F69L L218 stop
322b − +/− A123G T140A Q215 stop
340g − +/− V230I A249V
343d − − F37S S113T A141V S214P E227V
349h − +/− H12R D150G S153N
355i − +/− Q55L F127Y V202I L218 stop
358f − − A160V L189 stop
364i − − F169I S185 stop
366d − +/− I30T V171A T208M E246G
370i − − N139I Y195 stop
397f − − C224R
409b − +/− S83T P109S L218 stop
410b − +/− Y42 stop
The amino-acid sequences at the TatB-C fusion junction are as
follows (each one starting at S166 of TatB and ending at S2 of TatC):
a. SSSINLSMS.
b. SSSDNLSMS.
c. SSSDTLSMS.
d. SSSVTLSMS.
e. SSSVNLSMS.
f. SSSDKLSMS.
g. SSSITLSMS.
h. SSSKTLSMS.
i. SSSETLSMS.
Table 3. Single amino-acid substitutions in TatC that were tested for
activity and dominance.
D5E P54L K73E S148P G204R C224Ra
T11A M59K L74P D150G M205R
F37S V64E F94R D150Y D211R
P48L S66P V145E F165L Q215R
a. This substitution was found in conjunction with fused TatBC
(Table 2).
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The dominant negative TatC variants self-interact and
still bind TatB and TatA
In order to characterise the dominant negative single
amino-acid variants of TatC, we first tested whether TatC
P48L, TatC M59K, TatC S66P, TatC V145E and TatC
D150Y retained interactions with TatB and TatA. To facili-
tate this, the wild-type and variant TatC proteins were
supplied with a C-terminal hexahistidine tag and
co-overproduced with TatA and TatB from the pUNITAT2
Fig. 1. Phenotypic characterisation of TatC single amino-acid variants in a tatC− and tatC+ strain background. Spot tests of strain DADE
(ΔtatABCD, ΔtatE; top panel) or MC4100 (tat+; bottom panel) harbouring the pTAT1d vector encoding TatA, TatB and the indicated amino-acid
variant in TatC. Strain MC4100 also harboured the additional screening plasmid pTTC1 (since we noted that dominant negative phenotypes
were more clear-cut in the presence of the overproduced TorA–CAT fusion protein). tatC+ indicates strain DADE harbouring wild-type pTAT1d
(top panel) or strain MC4100 harbouring pTTC1 and wild-type pTAT1d (bottom panel) and tatC− is strain DADE harbouring the pTAT1d
parental plasmid, pUniprom. Strains were grown overnight in liquid media, diluted to give an OD600nm of 0.0001 and 5 μl aliquots were replica
spotted onto: LB medium (control), LB medium containing 2% SDS or M9 medium containing glycerol and TMAO. Strains were incubated for
3 days aerobically at room temperature for growth on LB and LB–SDS containing medium and anaerobically at 37°C for growth on
M9–glycerol–TMAO medium.
Fig. 2. Topological organisation of TatC and location of TatC variants analysed in this study. The diagram was generated using TEXtopo
(Beitz, 2000) and the positions of the transmembrane helices are indicated and single amino-acid residues that when substituted give rise to a
dominant negative phenotype are shown in red. The red boxes indicate the positions of truncations that, in the context of a TatB–TatC fusion,
give rise to dominant negative activity. Residues G144 and M205 that were mutated to cysteine and used for disulphide crosslinking analysis
are shown in yellow.
This figure is available in colour online at wileyonlinelibrary.com.
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plasmid (McDevitt et al., 2005). Membrane proteins were
solubilised with digitonin and TatC-his-containing com-
plexes isolated using nickel beads. It can be seen in Fig. 4
that TatB along with low levels of TatA specifically eluted
with TatC-his from the beads, even when dominant
negative substitutions were present in TatC. Therefore the
interaction of TatA and TatB partner proteins is not grossly
disrupted by the presence of dominant negative amino-
acid substitutions.
A potential explanation for the effect of the dominant
negative TatC substitutions that would not need to invoke
TatC oligomerisation is that the variants have additional
high affinity TatB binding sites (for example, by converting
one or more TatA binding sites to TatB binding), which
compete the available TatB protein away from wild-type
TatC. To test this possibility, we utilised strain MC75CH
that codes for a C-terminally his-tagged TatC at the native
chromosomal locus. We co-produced TatA and TatB along
with untagged wild-type or dominant negative P48L,
M59K, S66P, V145E or D150Y TatC variants. TatC variant
G204R was also analysed as a negative control. It can be
seen (Fig. 5) that TatB co-purifies with the his-tagged TatC
both in the presence of co-produced wild-type TatC and in
the presence of the dominant negative TatC variants. We
conclude that there is no evidence that the dominant
negative substitutions titrate TatB away from wild-type
TatC.
The bacterial two hybrid system developed by Karimova
et al. (1998) can be applied to assess interactions between
membrane proteins (e.g. Karimova et al., 2005). When one
TatC molecule was fused to the N-terminus of the ade-
nylate cyclase T18 fragment and a second to the
C-terminus of the T25 fragment, adenylate cyclase activity
Table 4. TatBC fusions and TatC truncations tested for dominance
in this study.
Clone name TatBC fusion sequence/TatC substitution
TatBC fusion2 tatB166SSSDNLSMStatC2
TatBC fusion6 tatB166SSSDKLSMStatC2
TatBC fusion9 tatB166SSSETLSMStatC2
TatCY42 stop No fusion, TatC Y42 stop
TatCS185 stop No fusion, TatC S185 stop
TatCL189 stop No fusion, TatC L189 stop
TatCE197 stop No fusion, TatC E197 stop
TatCL218 stop No fusion, TatC L218 stop
Fusion2Y42 tatB166SSSDNLSMStatC2, TatC Y42 stop
Fusion2E187 tatB166SSSDNLSMStatC2, TatC E187 stop
Fusion2L218 tatB166SSSDNLSMStatC2, TatC L218 stop
Fusion6A160V tatB166SSSDKLSMStatC2, TatC A160V
Fusion6L189 tatB166SSSDKLSMStatC2, TatC L189 stop
Fusion6A160VL189 tatB166SSSDKLSMStatC2, TatC A160V,
L189 stop
Fusion6AC224R tatB166SSSDKLSMStatC2, TatC C224R
Fusion9F169I tatB166SSSETLSMStatC2, TatC F169I
Fusion9S185* tatB166SSSETLSMStatC2, TatC S185 stop
Fusion9 F169I S185* tatB166SSSETLSMStatC2, TatC F169I,
S185 stop
Fig. 3. Phenotypic characterisation of TatBC fusions and TatC truncations in a tatC− and tatC+ strain background. Spot tests of strain DADE
(ΔtatABCD, ΔtatE; top panel) or MC4100 (tat+; bottom panel) harbouring the pTAT1d vector that contains the mutated tatABC operon encoding
TatC variants or TatB-C fusion proteins, as indicated. Strain MC4100 also harboured the additional screening plasmid pTTC1. tatC+ indicates
strain DADE harbouring wild-type pTAT1d (top panel) or strain MC4100 harbouring pTTC1 wild-type pTAT1d (bottom panel) and tatC− is strain
DADE harbouring the empty vector pUniprom. Strains were grown overnight in liquid media, diluted to give an OD600nm of 0.0001 and 5 μl
aliquots were replica spotted onto: LB medium (control), LB medium containing 2% SDS or M9 medium containing glycerol and TMAO.
Strains were incubated for 3 days aerobically at room temperature for growth on LB and LB–SDS containing medium and anaerobically at
37°C for growth on M9–glycerol–TMAO medium.
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was reconstituted, and strong β-galactosidase activity
could be measured (Fig. 6A). It should be noted that this
probably represents a direct TatC–TatC interaction rather
than being mediated through TatB because although the
BTH101 strain used for these experiments encodes chro-
mosomal tatABC/tatE, the TatC fusions are produced in
multicopy under the control of the strong lacUV5 promoter
(Karimova et al., 1998). We next assessed using this
method whether the five amino-acid substituted dominant
negative TatC variants produced as T25 fusion proteins
could interact with the wild-type TatC that was produced as
a fusion to T18. Figure 6A indicates that indeed interaction
between the wild-type and dominant negative variants of
TatC could be detected. For T25 fusions of four of the five
dominant negative TatC variants, M59K, S66P, V145E and
D150Y, the level of β-galactosidase activity measured in
the presence of T18 wild-type TatC was significantly higher
than that measured for the T25 wild-type TatC fusion.
We also assessed whether each of the dominant nega-
tive TatC variants could self-interact using this approach,
and indeed Fig. 6B shows that self-interaction could be
seen for each of the variants. The S66P variant gave
particularly high levels of β-galactosidase activity, signifi-
cantly above that seen for the wild-type TatC self-
Fig. 4. Dominant negative point substituted variants of TatC interact with TatB and TatA. Crude membrane fractions of the E. coli strain
DADE (ΔtatABCD ΔtatE) harbouring pREP4 (Zamenhof and Villarejo, 1972) and over-producing TatA, TatB and hexa-histidine-tagged wild-type
or amino-acid substituted TatC, as indicated were solubilised with digitionin and the TatC-his protein purified using nickel-charged beads as
described in Experimental Procedures. In each case a sample that was loaded onto the beads (load) along with the sample that was eluted
from the beads (elute) were separated by SDS–PAGE (12% acrylamide), electroblotted and immunoreactive bands were detected with either
anti-his, anti-TatB or anti-TatA antisera. As a control, solubilised membranes from strain DADE/pREP4 overproducing TatA, TatB and a
non-tagged variant of TatC (lanes labelled No his) were used to show that there was no unspecific binding of TatA and TatB to the beads. Five
microlitres of sample was loaded in each lane.
Fig. 5. Dominant negative point substituted variants of TatC do not prevent his-tagged wild-type TatC from interacting with TatB. Crude
membrane fractions of E. coli strain MC75CH (as MC4100, tatChis) harbouring pTTC1 and over-producing TatA, TatB and wild-type or
amino-acid substituted TatC, from pTAT1d as indicated, were solubilised with digitonin and the chromosomally encoded TatC-his protein from
the chromosome of strain MC75CH was purified using nickel-charged beads as described in Experimental Procedures. In each case, a
sample that was loaded onto the beads (load) along with the sample that was eluted from the beads (elute) were separated by SDS–PAGE
(12% acrylamide), electroblotted and immunoreactive bands were detected with either anti-His or anti-TatB. As a control, solubilised
membranes from strain MC4100[pTTC1] overproducing TatA, TatB and a non-tagged variant of TatC (lane labelled -his) were used to show
that there was no unspecific binding of TatB to the beads.
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interaction, whereas two of the variants, P48L and V145E,
gave β-galactosidase activity levels lower than the wild
type, but still significantly higher than the negative control.
The dominant negative TatC proteins can interact
with substrate proteins but are unable to trigger
TatA polymerisation
To ascertain which step/s in the Tat transport pathway
were blocked by the TatC dominant negative amino-acid
substitutions, we next examined whether the TatC substi-
tutions P48L, S66P, V145E or D150Y affected interaction
of substrate proteins with TatBC. It has been shown
previously that SufI can bind tightly to membranes con-
taining TatBC (Bageshwar et al., 2009) and that a ternary
complex can be purified following detergent extraction
(Tarry et al., 2009). We therefore designed a plasmid that
would allow co-production of TatB and TatC with a his-
tagged SufI precursor, isolated membrane fractions from
cells containing this plasmid, solubilised these with digi-
tonin and purified SufI-his using Ni-charged beads.
Figure 7A shows that following elution of bound SufI from
the beads, wild-type TatB and TatC could be co-eluted,
indicative of complex formation. Further control experi-
ments (Fig. 7A) showed that no TatB or TatC could be
recovered when the conserved twin-arginine motif of the
SufI signal peptide was mutated to twin lysine (a substi-
tution which is known to abolish targeting of SufI to the Tat
pathway; Stanley et al., 2000), nor when the TatC protein
harboured the F94A, E103A double substitution that is
known to block signal peptide binding (Holzapfel et al.,
2007; Rollauer et al., 2012; Alcock et al., 2013). However,
it can clearly be seen (Fig. 7B) that the dominant negative
TatC substitutions do not block substrate binding, since in
each case, the variant TatC proteins could be co-purified,
along with TatB, by interaction with his-tagged SufI.
Once a substrate is bound to the TatBC complex, the
next step of Tat transport is the recruitment of TatA, in
multiple copies, to assemble the active translocation site
(Mori and Cline, 2002; Alami et al., 2003; Alcock et al.,
2013). This can be visualised in intact E. coli cells using a
chromosomally encoded TatA–YFP protein. This fusion
protein, in the presence of TatBC and low levels of the
TatA paralogue TatE, supports full physiological Tat trans-
port activity (Alcock et al., 2013). When the Tat substrate
protein CueO is overproduced in this strain background,
bright foci of TatA–YFP can be observed by fluorescence
microscopy (Alcock et al., 2013; Fig. 8A). However, when
either the S66P or D150Y dominant negative substitutions
were present in TatC (which also carried a C-terminal
FLAG epitope in these experiments), TatA–YFP showed
only dispersed fluorescence even in the presence of over-
produced CueO (Fig. 8A). Western blotting analysis con-
firmed that the Tat components and CueO were present at
similar levels in all of the strains analysed (Fig. 8B). We
conclude that although the TatC dominant negative vari-
Fig. 6. Bacterial two hybrid analysis of TatC–TatC interaction.
A and B. Interactions between the indicated variants of TatC fused to either the T18 or T25 fragments of Bordetella pertussis adenylate
cyclase, as indicated. Error bars represent the standard error of the mean (n = 6; two technical replicates of three biological replicates).
Significance was assessed using Student’s t-test, where asterisk signifies P < 0.005 and double asterisks signifies P < 0.001 relative to the
value for T18-TatC + T25-TatC.
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ants are able to interact with substrate proteins, at least
two of them are unable to trigger the substrate-induced
recruitment of TatA.
The TatBC complex does not fully assemble in the
presence of dominant TatC variants
The experiments undertaken so far have established that
the dominant negative amino-acid substitutions of TatC do
not prevent TatC self-interaction, as assessed by the bac-
terial two hybrid assay, nor do they prevent association
with TatB or substrate protein. To determine whether they
result in any gross conformational or oligomer state
changes in the TatBC complex, BN-PAGE was performed
on digitonin-solubilised membranes from strain DADE
(ΔtatABCD, ΔtatE) producing the TatABC proteins from
the medium copy number pTAT1d plasmid.
Figure 9 shows that when the wild-type allele of tatC was
present on the plasmid, the major band cross-reacting with
both TatB and TatC antisera migrates at just over 440 kDa.
Other bands at lower molecular weight are also visible and
have been reported previously (e.g. Behrendt et al., 2007;
Orriss et al., 2007; Richter and Bruser, 2005). However,
when any of the five dominant negative amino-acid substi-
tutions were introduced into TatC, the 440 kDa TatBC
complex was no longer detected, and instead smaller
complexes that cross-reacted with both the TatB and TatC
antibodies accumulated migrating at approximately 100
and 150 kDa were observed. These small complexes
detected in the presence of dominant negative TatC vari-
ants migrated at the same size as the minor lower molecu-
lar weight bands detected for the wild-type TatC-containing
complexes. We therefore conclude that the dominant
negative amino-acid substitutions either greatly destabilise
Fig. 7. Dominant negative TatC proteins can be co-purified with the Tat substrate, SufI. Membrane fractions were prepared from strain DADE
(ΔtatABCD, ΔtatE) harbouring pREP4 and either pFAT75ΔASufIhisKK or pFAT75ΔASufIhis coding for wild-type or variant TatC (along with
wild-type TatB and his-tagged SufI) as indicated, and resuspended in buffer to give an equivalent protein concentration. Following
solubilisation with 1% digitonin, detergent-extracted proteins were loaded onto nickel-charged resin, washed with buffer containing 50 mM
imidazole and finally eluted from the column in the presence of 10 mM EDTA. Samples (5 μl) of the load and eluate fractions were separated
by SDS–PAGE (12% acrylamide) and analysed by immunoblotting with anti-his, anti-TatC and anti-TatB antibodies.
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the 440 kDa TatBC complex or prevent its assembly from
TatBC subcomplexes.
A TatC self-interaction site at the periplasmic
cap is maintained in the presence of dominant
negative substitutions
Crosslinking experiments have implicated the periplasmic
cap of TatC as a likely site of TatC self-interaction
(Punginelli et al., 2007; Zoufaly et al., 2012). Given that
the dominant negative amino-acid substitutions are
almost exclusively associated with this region, it is possi-
ble that they may perturb the ability of TatC to interact
through the cap and that this might account for the smaller
TatBC complexes seen on BN-PAGE. It was noted previ-
ously that when residue G144 in the second periplasmic
loop region was mutated to cysteine, an almost quantita-
tive self-crosslink was observed when the Tat proteins
were overproduced (Punginelli et al., 2007). To probe this
further, we expressed the G144C variant of TatC at close
Fig. 8. Substrate-induced assembly of TatA-YFP is blocked by the TatC S66P and D150Y mutations. The Tat substrate CueO was
overproduced from plasmid pQE80-CueO (Leake et al., 2008) in strain MΔABC-A λAry p101C*TatBCflag encoding TatB along with the
wild-type or dominant negative TatC variants as indicated, with a C-terminal FLAG tag on TatC.
A. Fluorescence micrographs showing the distribution of TatA-YFP following overproduction of CueO for the indicated TatC variants.
B. Isolated membranes of the same strains used for microscopy analysed by Western blot with antibodies against TatA, TatB or FLAG, or
whole cell extracts were analysed similarly with antibodies against CueO. Eighteen micrograms of membranes were loaded per lane. CueO
antibodies were raised in rabbits against the mature protein, and affinity purified.
Fig. 9. Blue native (BN)-PAGE analysis of TatBC complexes containing dominant negative TatC substitutions. Crude membrane fractions of
the E. coli strain DADE (ΔtatABCD ΔtatE) overproducing wild-type or P48L, M59K, S66P, V145E or D150Y amino-acid substituted TatC along
with TatA and TatB from the pTAT1d plasmid were solubilised using 2% digitonin and samples (approximately 200 μg protein) were analysed
by BN-PAGE. The arrows to the right indicate TatBC-containing complexes. The bottom panels show SDS–PAGE analysis of the same
solubilised samples.
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to native levels of expression from plasmid pTat101
(Kneuper et al., 2012), alongside TatA and TatB, and we
developed a method for disulphide crosslinking in living
cells. Figure 10B shows that in vivo, there is extensive
self-crosslinking of TatC through the introduced Cys
residue, even in the absence of exogenous oxidising
agent, strongly suggesting that there is a bona fide TatC
contact site close to this position.
We next tested whether the G144C crosslink could still
be detected when dominant negative substitutions were
also introduced into TatC. The position of the G144C
residue relative to each of the P48L, M59K, S66P, V145E
or D150Y dominant negative amino-acid substitutions is
shown in Fig. 10A. Strikingly, a very strong disulphide
bond at G144C was able to form despite introduction of
any of the dominant negative substitutions (Fig. 10B). We
conclude that this TatC self-interaction site is maintained
in the dominant negative TatC variants.
A substrate-induced crosslink at TatC M205C is blocked
by the TatC dominant negative substitutions
Previously, a second potential TatC self-interaction site
was found in transmembrane helix 5 of TatC, at M205C
(Kneuper et al., 2012; Rollauer et al., 2012). This site is
close to the TatB binding site, and the M205R inactivating
substitution of TatC can be suppressed by substitutions in
the transmembrane helix of TatB. To explore potential
TatC dimerisation mediated through this region of TatC,
we first introduced the M205R substitution into TatC and
investigated whether the variant proteins could interact in
the bacterial two-hybrid assay. Figure 6A shows that when
this point substitution was present in TatC fused to T25, it
was able to interact with a wild-type copy of TatC fused to
T18. However, when the TatC fused to T18 and T25 both
carried the M205R substitution, no dimerisation was
detected (Fig. 6B). Introduction of any of the dominant
negative amino-acid substitutions M59K, S66P, V145E or
D150Y alongside TatC M205R did not restore TatC dimeri-
sation (Fig. 6B). Therefore, we conclude that in the bac-
terial two hybrid assay, TatC self-interaction is likely
mediated by a dimer interface that encompasses trans-
membrane helix 5.
Disulphide crosslinking studies of TatC M205C have
shown that the residue exhibits unusual behaviour
because it can not only self-crosslink but can also
crosslink to cysteine residues introduced into the trans-
membrane helix of TatB (Kneuper et al., 2012; Rollauer
Fig. 10. A TatC self-crosslink in the periplasmic cap of TatC is not affected by dominant negative substitutions.
A. Periplasmic view of a homology model of E. coli TatC showing positions of the P48L, M59K, S66P, V145E and D150Y dominant negative
amino-acid substitutions (red) and G144C substitution (yellow) used for disulphide crosslinking analysis.
B. Intact cell suspensions (50 ml of culture of OD600nm = 0.15) of strain DADE (ΔtatABCD ΔtatE) co-producing TatA, TatB and the single
cysteine variant G144C of TatC together with additional TatC substitutions, as indicated, from pTat101 were left untreated (control sample; C),
or subjected to either oxidising (O) or reducing (R) conditions as described in Experimental Procedures. Samples (50 μg of membrane protein)
were resolved by SDS–PAGE (12% acrylamide), and TatC monomers and dimers visualised by western blotting.
This figure is available in colour online at wileyonlinelibrary.com.
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et al., 2012). However, as before, these experiments
were undertaken in vitro, with membranes containing
high levels of Tat components. To examine this potential
TatC interaction site under more native conditions, we
assessed whether a disulphide bond could be formed
between two TatC M205C variants in vivo when the Tat
components were produced at close to native level. As
shown in Fig. 11A, in vivo there was no detectable TatC
dimerisation unless the Tat substrate protein, CueO, was
co-overproduced, in which case a TatC dimer band was
clearly visible under oxidising conditions. We conclude
that M205C residues from neighbouring TatC proteins
must come into close proximity when substrates bind to
the TatBC complex.
To determine whether any of the dominant negative
substitutions P48L, M59K, S66P, V145E or D150Y
altered the crosslinking behaviour of M205C, the same
in vivo crosslinking experiments were carried out with
TatC M205C that additionally harboured a single domi-
nant negative substitution. Figure 11B shows that no
disulphide crosslink is able to form between M205C resi-
dues when any of the five dominant negative substitu-
tions are present, regardless of the presence of
overproduced CueO. It therefore appears that these
substitutions prevent the function of wild-type TatC by
blocking the formation of a transient TatC dimer that
forms in response to substrate binding during Tat protein
translocation.
Fig. 11. A substrate-induced TatC self-crosslink in transmembrane helix 5 of TatC.
A. Whole cells of strain DADE (ΔtatABCD ΔtatE) harbouring pTat101 co-producing TatA, TatB and the single cysteine variant M205C of TatC,
alone or with additional plasmid pQE80-CueO were cultured as described in Experimental Procedures and subjected to oxidising (O) or
reducing (R) conditions, or left untreated (control; C). Samples (50 μg of membrane protein) were resolved by SDS–PAGE (12% acrylamide),
and TatC monomers and dimers visualised by western blotting using an anti-TatC antibody.
B. Cells of the same strain harbouring pTat101 co-producing TatA, TatB and the single cysteine variant M205C of TatC together with the
indicated additional TatC substitutions alone (top panel) or with pQE80-CueO (middle and bottom panels) were treated as in part A and
samples (50 μg of membrane protein) were resolved by SDS–PAGE (12% acrylamide), and blotted with anti-TatC (middle panel) or anti-his
antibody (bottom panel). Note that the fast migrating band detected on the anti-his blot for the oxidised sample most probably represents a
crosslinked form of CueO containing an intramolecular disulphide.
TatC is a functional oligomer 123
© 2015 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd, Molecular Microbiology, 98, 111–129
Discussion
In this study we have sought to test whether oligomerisa-
tion of TatC is a functional requirement of the Tat pathway
by undertaking a genetic screen to identify mutant alleles
of tatC that interfere with the function of the wild-type
protein. Our success in isolating such mutants strongly
suggests that co-operation between at least two protom-
ers of TatC is an essential step in the protein translocation
pathway.
The dominant negative mutant alleles we isolated fell
into two classes. One class encoded TatBC fusion pro-
teins that frequently contained stop codon mutations
within tatC, leading to C-terminal truncations. Dissecting
out these mutations revealed that it was necessary for the
truncated TatC variants to be fused to TatB in order for
them to have dominant negative activity. This can be
rationalised if the truncated TatC proteins alone are
unable to stably interact with the TatBC complex, but the
TatB portion of the fusion integrates into the complex,
bringing the truncated TatCs into close proximity with the
wild-type protein. Since these mutant alleles are likely to
grossly perturb the structure and stability of dominant
negative variants, we did not study them further.
The second class of dominant negative mutant alleles
we isolated encoded one or more amino-acid substitu-
tions in TatC that predominantly localised to the first and
second periplasmic loops, which together form the peri-
plasmic cap region of the protein. These substitutions did
not prevent TatC from interacting with TatB or TatA, but
BN-PAGE analysis showed that TatBC complexes con-
taining these dominant negative amino-acid substitutions
did not assemble into the large (approximately 440 kDa)
hetero-oligomer formed from TatB and wild-type TatC.
Instead, smaller complexes, most likely subcomplexes of
the 440 kDa complex, accumulated. Other substitutions in
these loop regions have previously been noted to affect
assembly of the TatBC complex (Barrett et al., 2005;
Behrendt and Bruser, 2014), and of the thylakoid Hcf106-
cpTatC receptor complex (Ma and Cline, 2013). It there-
fore seems likely that at least one of the TatC contact sites
is mediated through the cap region of TatC.
However, the effect of these substitutions is not as
simple as abolishing TatC interaction via the cap. Disul-
phide crosslinking of residue G144C, which is present in
the cap region, was not affected by the introduction of the
single dominant negative substitutions, nor were disul-
phide crosslinks at A65C or G148C (not shown). Confor-
mational change at the cap region is likely to be important
during the different steps of protein translocation, for
example the G144C variant of TatC, which is extensively
disulphide-locked in vivo, is associated with low transport
activity (Punginelli et al., 2007). Furthermore, it has also
been noted that a disulphide crosslink at position L126 in
the cap region of thylakoid TatC decreased in intensity in
the presence of a Tat substrate (Aldridge et al., 2014). The
dominant negative point substitutions could potentially
exert their effect by stabilising one particular cap confor-
mation and preventing progression through the transport
cycle.
Transmembrane helix 5 of TatC is a short, sharply
kinked helix that is too short to fully span the lipid bilayer
(Rollauer et al., 2012; Ramasamy et al., 2013). Several
studies have pinpointed the C-terminal (periplasmic) end
of this helix as playing a critical role in Tat transport. For
example residues in this helix interact with TatB (Kneuper
et al., 2012; Rollauer et al., 2012), and in the chloroplast
Tat system, this helix of cpTatC has been shown to inter-
act with the TatA orthologue, Tha4, and with substrate
signal peptides (Aldridge et al., 2014). In all of these
studies, TatC self-contacts were also detected at specific
positions within this helix. Here we noted that this helix
also forms part of a TatC dimer interface detected using
the bacterial two-hybrid system. When the Tat-inactivating
M205R substitution, which falls close to the C-terminal
end of helix 5, was introduced into TatC, no dimerisation
was detected, supporting the inference from crosslinking
that this is a site of self-interaction. However, when we
undertook disulphide crosslinking experiments in vivo, we
did not detect disulphide formation at TatC M205C unless
we overproduced a substrate protein. We interpret these
findings to suggest that dimerisation at M205C is transient
and occurs at one of the stages in the Tat transport cycle,
most likely following engagement of a signal peptide with
the TatBC complex. We suggest that in the resting state,
the M205C residues from adjacent TatC proteins are held
apart, for example by the presence of an intervening TatB
or TatA molecule, and that there is conformational rear-
rangement upon signal peptide binding to bring M205C
residues into close proximity. This would also explain why
the M205 dimer interface is detected in the bacterial two
hybrid system, since in these experiments, the TatC
fusions are overproduced in the presence of only native
levels of the TatB or TatA partner proteins that may nor-
mally mask this binding site.
Aldridge et al. (2014) have reported a pea chloroplast
TatC–TatC disulphide crosslink at a position (V270) corre-
sponding to L206 in E. coli TatC and thus directly adjacent
to the M205C crosslink analysed here. The crosslinking at
this position in the chloroplast TatC displays interesting
behaviour since it self-crosslinks in the absence of Tha4
(the chloroplast equivalent of TatA) but in the presence of
Tha4 preferentially crosslinks to Tha4 instead of a neigh-
bouring TatC. However, in the additional presence of sub-
strate, the TatC homodimeric crosslink is not restored, in
contrast to the behaviour of the E. coli TatC M205C
crosslink, which is generated only when substrate is over-
produced. Instead, the cpTatC-Tha4 crosslink diminishes
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and there is a crosslink between cpTatC V270C and the
substrate signal peptide (Aldridge et al., 2014). It is likely
that these differences in crosslinking behaviour reflect the
different positions on transmembrane helix 5 that are prob-
ably occupied by these two residues, with E. coli TatC
L206/cpTatCV270 predicted to point into the concave face
of TatC, whereas M205 is predicted to point outwards.
None-the-less, the data presented here and in the study of
Aldridge et al. (2014) consistently indicate that there is
change in the dimerisation interface at the periplasmic
(luminal) end of TatC helix 5 with differing states of the Tat
translocase. That the dominant negative variants of TatC
are unable to generate the homodimeric crosslink at
M205C in the presence of substrate, despite retaining the
ability to interact with substrate, adds further support to the
notion that these variants are unable to trigger events,
including TatA recruitment and potentially TatBC reorgani-
sation, that might occur following binding of substrates.
Experimental procedures
Bacterial strains, plasmids and growth conditions
Strains MC4100 [F−, [araD139]B/r, Δ(argF-lac)U169, λ−, e14-,
flhD5301, Δ(fruK-yeiR)725(fruA25), relA1, rpsL150(StrR),
rbsR22, Δ(fimB-fimE)632(::IS1), deoC1 – (Casadaban and
Cohen, 1979)] and DADE [As MC4100, ΔtatABCD, ΔtatE –
(Wexler et al., 2000)] were used in this study. Strain MC75CH
is derived from MC4100 but encodes a hexahistidine tag
coding sequence at the 3′ end of tatC and has been
described previously (McDevitt et al., 2006). Bacterial two
hybrid analysis was carried out in strain BTH101 [F− cya-99,
araD139, galE15, galK16, rpsL1 (Strr), hsdR2, mcrA1, mcrB1
(Karimova et al., 2000)]. Strain MΔABC-A* λAry, which is
deleted for tatABC at the native chromosomal location and
harbours a tatA-yfp allele integrated at the attB site, was used
for fluorescent microscopy experiments and has been
described previously (Alcock et al., 2013).
To produce TatC as a fusion protein to the N-terminus
of the T18 fragment of adenylate cyclase of Bordetella
pertussis, tatC was amplified with oligonucleotides
pUT18TatCforXba and pUT18TatCrevBam (Table S2), using
MC4100 chromosomal DNA as template. The resultant
product was digested with XbaI and BamHI and cloned into
pUT18 (Karimova et al., 2001) to give plasmid pUT18-TatC.
Similarly, TatC was produced as a C-terminal fusion to
the B. pertussis adenylate cyclase T25 fragment following
amplification with oligonucleotides pT25TatCforBam and
pT25TatCrevKpn, digestion with BamHI and KpnI and cloning
into pT25 (Karimova et al., 1998). Plasmid pTAT1d contains a
modified tatABC operon expressed from the native tatA pro-
moter in plasmid pT7.5 and pTTC1 encodes CAT fused to the
TorA signal peptide, also driven from the tatA promoter – both
have been described previously (Maldonado et al., 2011b).
For TatC purification of plasmid-encoded his-tagged TatC
variants, these were co-produced with TatA and TatB from
plasmid pUNITAT2 (McDevitt et al., 2005). To co-produce TatB
and TatC variants along with a C-terminally his-tagged SufI
protein, plasmid pFAT75ΔA (Tarry et al., 2009) was modified
as follows. First the 3′ part of the tatC gene on this plasmid was
modified by introduction of the tatC stop codon, followed by
ApaI restriction site. This was achieved by amplifying a portion
of tatC using oligonucleotides tatC6741 and tatCstopApa
(Table S2), digestion with Eco47III and BglII and cloning into
pFAT75ΔA cut with same enzymes to give pFAT75ΔAApa.
Next, the sufI gene was amplified with oligonucleotides
SufIstartApa and SufIBglII (Table S2), digested with ApaI
and BglII fragments and cloned into similarly digested
pFAT75ΔAApa to give pFAT75ΔASufIhis. In parallel, a sufI
gene encoding for a twin lysine substitution of the twin-arginine
motif of the SufI signal peptide was also amplified using pT7.5
SufIKK as a template (Stanley et al., 2000) and similarly
cloned to give pFAT75ΔASufIhisKK. For in vivo disulphide
cross-linking experiments, TatC variants were co-produced
alongside TatA and TatB from plasmid pTat101 or TatB only
from plasmid pTatBC101, both constructed with the vector
backbone pTH19kR and used for low-copy expression
(Kneuper et al., 2012; Alcock et al., 2013). For TatC detection
following production from very low copy number plasmids, a
FLAG epitope coding sequence was introduced at the 3′ end of
tatC on plasmid p101C*TatBC using primers p101C*BCflag_F
and p101C*BCflag_R (Table S2). A complete list of all plas-
mids used and constructed in this study is given in Table S1.
To introduce nucleotide exchanges into tatC, the Quick-
change site-directed mutagenesis protocol (Stratagene) was
used – all primers used for site-directed mutagenesis and
other aspects of this study are listed in Table S2. Amplified
products were digested with DpnI and subsequently used to
transform E. coli strain DH5α [F− φ80dlacZM15 (lacZYA-
argF)U169 deoR recA1 endA1 hsdR17(r k−, mk+) phoA
supE44 thi-1 gyrA96 relA1 λ−]. Modified plasmids were iso-
lated and the introduction of the selected mutations was
confirmed by sequencing of the whole tatABC operon.
Phenotypic growth screening in the presence of chloram-
phenicol was undertaken as described previously, with the
exception that 200 μg ml−1 chloramphenicol was used
(Maldonado et al., 2011b; Kneuper et al., 2012). Growth of
strains on 2% SDS, or anaerobically with glycerol and
TMAO, was tested as described previously (Buchanan
et al., 2002; Palmer et al., 2010). For direct comparison of
the activity of Tat systems harbouring variants of TatC, 5 ml
liquid cultures was grown in Luria–Bertani (LB) medium
containing the appropriate antibiotics with shaking at 37°C
for 8 hours and diluted in phosphate-buffered saline to give
a final OD600 of 0.0001. Samples (5 μl) of each culture were
replica-spotted onto LB agar, LB agar 2% SDS and TMAO
plates each containing the appropriate antibiotics and incu-
bated as previously described (Buchanan et al., 2002;
Palmer et al., 2010). For measurement of TMAO reductase
activity, strains were grown anaerobically overnight at 37°C
in LB containing 0.4% (w/v) TMAO and 0.5% (v/v) glycerol.
Periplasmic fractions were prepared using ethylenediammi-
netetraacetate (EDTA)/lysozyme treatment and TMAO:ben-
zyl viologen oxidoreductase activity in the periplasmic
fraction was measured as described previously (Palmer
et al., 2010).
Bacterial two-hybrid analyses were performed as described
by Karimova et al. (1998; 2001). For quantitative assessment,
β-galactosidase assays were performed according to the
method of Miller on strains grown to exponential phase at 30°C
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and permeabilised with toluene (Miller, 1992). Data shown are
an average of two technical replicates performed on three
biological replicates.
BN-PAGE
An overnight culture of the strains of interest was inoculated
at 1:100 dilution into 50 ml of LB supplemented with appro-
priate antibiotics and incubated with shaking at 37°C until an
OD600nm of 0.6 was reached. All subsequent steps were
undertaken at 4°C. Cells were pelleted by centrifugation, then
washed with 50 mM Tris–HCl, pH 7.5 buffer and resus-
pended in 2 ml of the same buffer supplemented with
EDTA-free protease inhibitor (Roche). Cell suspensions were
lysed by sonication and the lysates were clarified by centrifu-
gation at 17,000 × g for 10 min. Membranes were pelleted by
ultracentrifugation at 220,000 × g for 30 min and resus-
pended in 100 μl of 50 mM Tris–HCl pH 7.5 10% glycerol
buffer. Total membrane protein was quantified using the DC
Protein Assay kit (Bio-Rad).
Membrane samples (400 mg of protein) were pelleted and
then solubilised in 40 μl of Buffer A (50 mM NaCl, 50 mM
imidazole, 2 mM 6-aminohexanoic acid, 1 mM EDTA, pH 7.0)
containing 2% digitonin for 30 min on ice. Unsolubilised
material was pelleted by centrifugation at 220,000 × g for
20 min and the supernatant was removed and supplemented
with 5% glycerol and 0.2% Coomassie Brilliant Blue. Blue
native polyacrylamide gel electrophoresis (BN-PAGE) on
solubilised samples was carried out using precast gels
(Novex Bis-Tris NativePAGE mini gel 4–16%, Life Technolo-
gies) and buffers (anode, cathode B and cathode B10) as
described in Wittig et al. (2006). Separated proteins were
transferred to polyvinylidene difluoride membrane using an
iBlot 1 dry transfer device (Life Technologies) and the mem-
branes were destained with 25% methanol 10% acetic acid
solution and pure methanol as described (Wittig et al., 2006).
Immunoreactive bands were visualised using an anti-TatC
peptide antibody (raised in rabbits to the amino-acid
sequence GKGRNREEENDAEAESEKTEE) obtained from
GenScript (Piscataway, USA) that was used at 1/5000 dilu-
tion, and an anti-TatB antibody [also raised in rabbits
(Sargent et al., 2001)] or a goat anti-rabbit HRP conjugated
antibody (BioRad) used at 1/10,000 dilution diluted at 1/1000,
with the Clarity Western ECL Substrate Kit (BioRad) and
recorded with the GeneGNOME camera (Syngene).
A small volume of the same solubilised membrane frac-
tions were also analysed by denaturing SDS–PAGE (12%
acrylamide) (Laemmli, 1970), by mixing with 1 × Lammli
buffer. Proteins were transferred to nitrocellulose membranes
using the iBlot dry transfer device and incubated with the
same anti-TatC (1/10,000 dilution) and anti-TatB (1/1000 dilu-
tion) antibodies. Immunoreactive bands were visualised as
before.
Purification of TatC-his and SufI-his complexes
The purification of TatC-his and SufI-his-containing com-
plexes produced in strain DADE/pRep4 from the pUNITAT2
and pFAT75ΔASufIhis plasmids, respectively, or of chromo-
somally encoded TatC-his from strain MC75CH was per-
formed as described in Fritsch et al. (2012) with the following
modifications: Buffer B (20 mM MOPS pH 7.2, 200 mM NaCl)
was used as resuspension buffer; membrane protein was
solubilised using 1% digitonin in Buffer B supplemented with
50 mM imidazole (25 mM imidazole for chromosomally
encoded TatC-his); Buffer B containing 50 mM imidazole
(25 mM imidazole for chromosomally encoded TatC-his) and
0.1% digitonin was used as wash buffer; and Buffer B con-
taining 10 mM EDTA and 0.1% digitonin was used as elution
buffer (as protein samples in high concentrations of imidazole
run poorly for BN-PAGE).
Samples from each step of the purification were diluted in
1× Lammli buffer, separated by SDS–PAGE (12% acryla-
mide) transferred to nitrocellulose membrane and immunob-
lotted with anti-his-HRP (Abcam, 1/50,000 dilution to
detect TatC-his and 1/20,000 to detect SufI-his), anti-TatC
(1/10,000, to detect untagged TatC bound to SufI-his) anti-
TatB (1/1000) and anti-TatA [raised in rabbits and used at
1/10,000 dilution (Sargent et al., 2001)].
Goat anti-rabbit and anti-mouse HRP conjugated antibod-
ies (BioRad) were used at 1/10,000 dilution.
Disulphide crosslinking
In vivo disulphide cross-linking experiments were performed
using the tat− strain DADE, with Tat proteins produced
from plasmid pTatBC101. For experiments also involving
co-overproduction of substrate protein, the strain additionally
contained plasmid pQE80-CueO (Leake et al., 2008). Fresh
LB medium was inoculated with a 1:100 dilution of an over-
night culture of the strains of interest, supplemented with
1 mM of isopropyl-β-D-galactopyranoside to induce the
expression of CueO-his as required, and cultured aerobically
at 37°C until an OD600nm of 0.3 was reached. At this point,
three 25 ml aliquots of each culture were withdrawn and each
was supplemented with fresh LB medium to a final volume of
50 ml. One sample was left untreated as a control, a second
was supplemented with copper–phenanthroline to a final con-
centration of 0.3 mM (oxidising conditions) and the third incu-
bated with 10 mM dithiothreitol (reducing conditions). Cells
were incubated at 37°C with agitation for 15 min, harvested,
resuspended and free sulphydryls quenched by addition 1 ml
of 20 mM Tris–HCl, pH 7.5, 200 mM NaCl, 12 mM EDTA,
8 mM N-ethylmaleimide. Following supplementation with pro-
tease inhibitor cocktail (Roche), cell membranes were
extracted using the protocol described earlier and resus-
pended in 40 μl of Buffer C (50 mM Tris–HCl, pH 7.5, 5 mM
MgCl2, 10% glycerol). A sample of the supernatant following
ultracentrifugation was retained as the soluble cell fraction.
Fifty micrograms of total membrane protein and 20 μl of ultra-
centrifugation supernatant, both in 1× Lammli buffer, were
separated by SDS–PAGE and blotted with anti-TatC
(1/10,000) and anti-his non-conjugated (1/2000) antibody (to
detect his-tagged CueO) respectively. A goat anti-mouse
HRP conjugated antibody (BioRad) was used at 1/10,000
dilution.
Fluorescence microscopy
Cells were prepared for microscopy as previously described
(Alcock et al., 2013). Cells were imaged by pseudo total
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internal reflection fluorescence imaging as previously
described (Alcock et al., 2013), with the following modifica-
tions: A 532 nm, 50mW, solid-state laser (Suwtech) was
used, and excitation light focused at the back of an oil immer-
sion objective lens (100×∼ Plan Apo N.A. 1.49; Nikon). The
power entering the back of the objective was 10.8 mW, result-
ing in a power density in the image plane of 137 μW μm−2. A
532 nm LP emission filter was used (Semrock), and data
were collected at 20 ms exposure times. For figure compo-
sition, image stacks were imported into MATLAB (Math-
Works). Image stacks averaged over 40 ms were scaled to
display 1500 arbitrary units (a.u.) as the minimum (black) and
7500 a.u. as the maximum (white) and were exported as
PNG files. The CueO antibody used to analyse CueO levels
in these experiments has been described previously (Alcock
et al., 2013), and the Sigma anti-FLAG M2 antibody was
used to detect TatC-FLAG.
Homology modelling of E. coli TatC
Modeller 9v9 (Sali and Blundell, 1993) was used to create the
homology model of E. coli TatC, based on the X-ray structure
of the A. aeolicus protein (PDB: 4B4A).
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